tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Prakhar Agrawal, 34 are a BUY (91.89%), 3 are a HOLD (8.11%).
Analyst Prakhar Agrawal, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 35.99% that have a potential upside of 49.93% achieved within 115 days.
Prakhar Agrawal’s has documented 70 price targets and ratings displayed on 16 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on MLTX, MoonLake Immunotherapeutics at 23-Sep-2024.
Analyst best performing recommendations are on NEXI (NEXIMMUNE).
The best stock recommendation documented was for DICE (DICE MOLECULES HOLDINGS LLC) at 9/14/2022. The price target of $36 was fulfilled within 27 days with a profit of $16.39 (83.58%) receiving and performance score of 30.96.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$100
$0.01 (0.01%)
$120
3 years 13 days ago
(09-Feb-2022)
3/5 (60%)
$6.56 (7.02%)
256
Hold
$100
3 years 1 months 26 days ago
(27-Dec-2021)
4/6 (66.67%)
$9.27 (10.22%)
204
Hold
$100
$0.01 (0.01%)
$102
3 years 2 months 7 days ago
(15-Dec-2021)
3/5 (60%)
$7.15 (7.70%)
309
Hold
$79
3 years 2 months 7 days ago
(15-Dec-2021)
5/5 (100%)
$33.14 (72.26%)
401
Hold
$100
$0.01 (0.01%)
3 years 2 months 7 days ago
(15-Dec-2021)
3/4 (75%)
$7.15 (7.70%)
557
Which stock is Prakhar Agrawal is most bullish on?
What Year was the first public recommendation made by Prakhar Agrawal?
